Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (121-130 of 1,622) with videos related to

Pageof 163
Sort By:
The Oncologist|March 25, 2016
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: Where Do We Go From Here?Maurie Markman
Seminars in Oncology|June 1, 1985
The intracavitary administration of cytarabine to patients with nonhematopoietic malignancies: pharmacologic rationale and results of clinical trialsM Markman
The Western Journal of Medicine|May 1, 1986
Response of paraneoplastic syndromes to antineoplastic therapyM Markman
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
Supportive careMaurie Markman
The Hastings Center Report|December 24, 2002
Advertising genetic testingMaurie Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2002
Safety issues in using complementary and alternative medicineMaurie Markman
Medgenmed : Medscape General Medicine|June 21, 2003
Challenging ovarian cancer: how can we improve quantity and quality of life?Maurie Markman
Obstetrical & Gynecological Survey|September 1, 1987
Intraperitoneal chemotherapy as treatment of ovarian carcinoma: why, how, and when?M Markman
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Supportive careMaurie Markman
Gynecologic Oncology|July 4, 2006
Descriptions in the peer-reviewed literature of the results of phase 2 chemotherapy trials involving gynecologic malignancies: a call for greater objectivityMaurie Markman
Pageof 163

Showing results (121-130 of 1,622) with videos related to

Sort By:
Pageof 163
The Oncologist|March 25, 2016
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: Where Do We Go From Here?Maurie Markman
Seminars in Oncology|June 1, 1985
The intracavitary administration of cytarabine to patients with nonhematopoietic malignancies: pharmacologic rationale and results of clinical trialsM Markman
The Western Journal of Medicine|May 1, 1986
Response of paraneoplastic syndromes to antineoplastic therapyM Markman
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
Supportive careMaurie Markman
The Hastings Center Report|December 24, 2002
Advertising genetic testingMaurie Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2002
Safety issues in using complementary and alternative medicineMaurie Markman
Medgenmed : Medscape General Medicine|June 21, 2003
Challenging ovarian cancer: how can we improve quantity and quality of life?Maurie Markman
Obstetrical & Gynecological Survey|September 1, 1987
Intraperitoneal chemotherapy as treatment of ovarian carcinoma: why, how, and when?M Markman
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Supportive careMaurie Markman
Gynecologic Oncology|July 4, 2006
Descriptions in the peer-reviewed literature of the results of phase 2 chemotherapy trials involving gynecologic malignancies: a call for greater objectivityMaurie Markman
Pageof 163